RomaineCharlesNicholsJr.MD

PubMed

• 78 citations
  Comparative effectiveness study of patient‐reported outcomes after proton therapy or intensity‐modulated radiotherapy for prostate cancer
  Bradford S. Hoppe, Jeff M. Michalski, Nancy P. Mendenhall, Christopher G. Morris, Randal H. Henderson
  Cancer. 2014-04-01
• 80 citations
  Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer
  Curtis Bryant, Tamara L. Smith, Randal H. Henderson, Bradford S. Hoppe, William M. Mendenhall
  International Journal of Radiation Oncology, Biology, Physics. 2016-05-01
• 13 citations
  Postoperative Proton Therapy in the Management of Stage III Thymoma
  Nicolas Figura, Bradford S. Hoppe, Stella Flampouri, Zhong Su, Omeni Osian
  Journal of Thoracic Oncology. 2013-05-01

Journal Articles

• Proton-Based Chemoradiation for Synchronous Bilateral Non-Small-Cell Lung Cancers: A Case Report.  
  Wenyin Shi, MD, PhD; †Romaine C. Nichols,Jr., MD. †Stella Flampouri, PhD; †Zuofeng Li, D.Sc.; †Wen Hsi, PhD; †Bradford Hoppe MD, †Randall H. Henderson MD, MBA, Nancy P..., Thoracic Cancer
• Tumor Shrinkage during proton-based chemo-radiation for non-small-cell lung cancer may necessitate a adaptive replanning during treatment.  
  Shi W, Nichols RC Jr, Flampouri S, Hsi W, Li, Z, Henderson RH, Mendenhall NP, Hoppe BS, Hong Kong Journal of Radiology
• Proton therapy with concurrent chemotherapy for Non-Small Cell Lung cancer: Technique and early outcomes.  
  Hoppe BS, Flampouri S, Henderson RH, Pham D, Bajwa A, D'Agostino H, Huh SN, Li Z, Mendenhall NP, Nichols RC Jr, CLC
• Selective Nodal Irradiation of Regionally Advanced Non-small-cell Lung Cancer with Proton Therapy and IMRT: A Dosimetric Comparison.  
  Nichols RC Jr, Huh SH, Henderson RH, Li, Z, Flampouri S, D'Agostino HJ, Cury JD, Pham DC, Mendenhall NP, Hoppe BS, Thoracic Cancer
• When Is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?  
  Mendenhall WM, Hoppe BS, Nichols RC Jr, Henderson RH, Mendenhall NP, Am J Clin Oncol. 2012 Jan 10. [Epub ahead of print] PMID: 22237149
• T2-T3 Carcinoma of the Supraglottic Larynx: A Comparison of Surgery and Radiotherapy.  
  Fein DA, Nichols RC Jr, Lee WR, Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ, Million RR, Radiation Oncology Investigations 2:237-244 (1995)
• Join now to see all

Abstracts/Posters

• Feasibility of daily subcutaneous amifostine administration with fractionated radiotherapy for head and neck and non-small cell lung cancers.
  Nichols RC Jr, Henderson HR, Moss D, American Society for Clinical Oncology, Vol. 22:2003 (ASCO abstr. 3187)
• Radiation dose escalation in patients with regionally advanced non-small cell lung cancer facilitated by the use of the cytoprotectant amifostine.
  Nichols RC Jr, Neuenfeldt LM, England GJ, Mahmood SK, Nanfro JJ, Malamud FC, Sweetser MG, Varner JC, Gainer C, 4th international Chicago symposium on malignancies of the chest and head and neck, Chicago, Illinois
• 3-year results of RTOG-0012 randomized phase II study of neoadjuvant combined modality chemoradiation for distal rectal cancer.
  Mohiuddin M, Garcia M, Mitchell E, Hanna N, Yuen A, Nichols RC Jr, Share RE, Hayostek C, Willett C, 48th annual meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, Pennsylvania
• Changes in gene expression induced by chemoradiation in advanced cervical carcinoma: A microarray study of RTOG C-0128.
  Zempolich K, Milash B, Fuhrman C, Robert F, Greven K, Ryu J, Forbes A, Kerlin K, Nichols RC Jr, Gaffney DK, 47th annual meeting of the American Society for Therapeutic Radiology and Oncology, Denver, Colorado
• Radiation dose escalation in patients with non-small cell lung cancer facilitated by the use of the cytoprotectant amifostine.
  Nichols RC Jr, Neuenfeldt LM, England GJ, Mahmood SK, Nanfro JJ, Malamud FC, Sweetser MG, Varner JC, Gainer C, world conference on lung cancer, Barcelona, Spain
• Ongoing, prospective multicenter safety study of subcutaneous amifostine for non-small cell lung cancer (NSCLC).
  Nichols RC Jr, Fullmer KR, Published abstract in the proceedings of the American Society for Clinical Oncology, Vol. 23:2005
• Rectal tolerance for patients receiving dose escalated external beam radiotherapy or IMRT for localized prostate cancer.
  Nichols RC Jr, Moss DC, Varner JC, Neuenfeldt LM, Varner JC, 1st annual ASCO/ASTRO multidisciplinary prostate cancer symposium, Orlando, Florida
• Effect of subcutaneous amifostine on systolic blood pressure in patients receiving daily fractionated radiotherapy.
  Nichols RC Jr, Henderson HR, Mahmood SK, Malamud FC, American Society for Clinical Oncology, Vol. 22:2004 (ASCO abstr. 8176)
• Randomized phase II trial of preoperative combined modality chemoradiation for distal rectal cancer.
  Mitchell EP, Winter K, Mohiuddin M, Hanna A, Yuen C, Nichols RC Jr, Share C, Hayostek C, Willet C, American Society for Clinical Oncology, Vol. 22:2004 (ASCO abstr. 3535)
• Tangential breast conserving radiotherapy with multileaf collimation (MLC) may reduce scatter radiation dose to the contralateral breast compared to treatment with con...
  Nichols RC Jr, Moss DC, Varner JC, Rivard AA, Kinsey SW, Bruce WG, Ahmad A, Pappas JC, Neuenfeldt LM, 6th annual Lynn Sage breast cancer symposium, Chicago, Illinois
• Results of RTOG-0012 randomized phase II study of neoadjuvant combined modality chemoradiation for distal rectal cancer.
  Mohiuddin, M, Winter K, Mitchell E, Hanna N, Yuen A, Nichols RC Jr, Shane RE, Hayostek C, Willett C, 46th annual meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, Pennsylvania
• Does obesity increase positioning uncertainty for men undergoing prostate IMRT?
  Nichols RC Jr, Gainer C, Neuenfeldt LM, Varner JC, Hitt WT, Kyker JS, Adams JP, Dunn NP, Healy DC, Ramos CE, 3rd annual ASCO/ASTRO/SUO multidisciplinary prostate cancer symposium, Orlando, Florida
• Internal mammary chain radiotherapy using partially deep tangents: How many intercostals spaces can we safely cover?
  Nichols RC Jr, Moss DC, Rivard AA, Wilson TR, Reiss GE, Terracina DL, Osborn RB, Wilson RB, Bruce WG, Morris RC, Richards JJ, Kinsey SW, Mockler RA, Lydick K, 3rd annual Lynn Sage breast cancer symposium, Chicago, Illinois
• Tissue inhomogeneity correction in high dose conformal radiotherapy for lung cancer demonstrates increased tumor dose without substantial increase in the percentage of...
  Nichols RC Jr, Moss DC, Ortega VM, Dent WW, Cvitkovich DG, Ramirez JM, Moriarty TG, Lydick K, 2nd international Chicago symposium on malignancies of the chest and head and neck, Chicago, Illinois
• Post-implant instructions to patients after prostate brachytherapy.
  Moss DC, Nichols RC Jr, Lydick K, annual meeting of the American Society for Therapeutic Radiology and Oncology, Boston, Massachusetts
• T2-T3 carcinomas of the supraglottic larynx – results of surgery and/or irradiation with multivariate analysis.
  Nichols RC Jr, Freeman D, 22nd annual radiation oncology clinical research seminar, University of Florida, Gainesville, Florida
• Sarcomas of the hand, wrist and foot.
  Nichols RC Jr, Brant T, 21st annual radiation oncology clinical research seminar, University of Florida, Gainesville, Florida
• Squamous cell carcinoma of the lip.
  Nichols RC Jr, McCollough M, 20th annual radiation oncology clinical research seminar, University of Florida, Gainesville, Florida
• Risk factors for the development of early, severe aortic stenosis.
  Nichols RC Jr, Mohler ER, New Jersey associates day meeting of the American College of Physicians, Eatontown, New Jersey
• The MAC clinical workstation project.
  Nichols RC Jr, Stair T, University of Tennessee information technology in the health sciences conference, Memphis, Tennessee
• Esophageal cancer: Neoadjuvant and adjuvant therapies.
  Hoppe BS, Nichols RC Jr, Northeast Florida Medicine. Spring
• Proton radiotherapy for prostate cancer is not associated with post treatment testosterone suppression.
  Nichols RC Jr, Morris CG, Hoppe BS, Henderson RH, Marcus RB, Mendenhall WM, Li Z, Williams CR, Costa JA, Mendenhall NP, 51st annual meeting of the American Society for Therapeutic Radiology and Oncology, Chicago, Illinois
• Proton therapy with concomitant capecitabine for pancreatic and ampullary adenocarcinomas is associated with a low incidence of gastrointestinal toxicity.
  Romaine C Nichols MD, Thom George MD, Robert Zaiden MD, Stephen Hochwald MD, Ziad Awad MD, Meng Wei Ho PhD, Zuofeng Li PhD, Nancy P Mendenhall MD, William M Mendenhall..., 2012 annual meeting of the Pancreas Club, San Diego, California
• Proton Therapy May Allow Elective Nodal Coverage in the Setting of Neoadjuvant Radiotherapy for Pancreatic Head Cancers Without Significantly Increasing Normal Tissue ...
  R. Y. Lee1, R. C. Nichols2, S. N. Huh2, M. W. Ho2, Z. Li2, Z. T. Awad3, H. J. Asbun4, J. A. Stauffer4, S. N. Hochwald3, B. S. Hoppe2, Proton Therapy Cooperative Oncology Group Meeting #51, Seoul, Korea
• Case report: Recurrent desmoid tumor of the right flank managed with proton therapy.
  Whoon Jong Kil, MDa,R. Charles Nichols, Jr., MD a, Pratibha Gupta, MDb, Soon Y. Huh,PhD, Meng Wei Ho, MSc,Zuofeng Li, DSc. John Kilkenny, MD, uf surgeryRobert Zlotecki..., Proton Therapy Cooperative Oncology Group Meeting #51, Seoul, Korea
• Join now to see all

Lectures

• Evidence for the Role of proton therapy for pancreatic cancer. 
  IBA ASTRO symposium – San Diego, California
• Proton Therapy for Pancreatic Cancers. 
  Mayo Clinic GI Tumor Board, 2011, UF Gainesville GI Research Meeting, 2011
• Proton Therapy, an Overview. 
  Georgetown University Department of Radiation Oncology – Guest Professor
• Proton therapy in the treatment of non-small cell lung cancer. 
  Central European Lung Cancer Conference, Prague, Czech Republic
• Proton Therapy for Pancreatic Cancer 
  http://mediasite.med.upenn.edu/Mediasite/Play/e72e8491ef1346c8aa6b5633e6174f301d?catalog=5078bba3-1f
• Join now to see all